We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
-14.01%
1 Year Est. Return
+16.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$347M
AUM Growth
-$90M
Cap. Flow
-$21.1M
Cap. Flow %
-6.07%
Top 10 Hldgs %
37.65%
Holding
282
New
14
Increased
8
Reduced
67
Closed
24

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.3M
2
XOM icon
ExxonMobil
XOM
+$3.3M
3
DE icon
Deere & Co
DE
+$3.21M
4
LHX icon
L3Harris
LHX
+$2.01M
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$591K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$8.29M
2
TSM icon
TSMC
TSM
+$7.12M
3
GNRC icon
Generac Holdings
GNRC
+$4.26M
4
JPM icon
JPMorgan Chase
JPM
+$3.53M
5
MS icon
Morgan Stanley
MS
+$2.94M

Sector Composition

Rank Sector Weight
1 Technology 27.42%
2 Healthcare 17.14%
3 Financials 13.56%
4 Consumer Discretionary 11%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$454B
$6.38M 1.84%
149,743
-7,599
-5% -$364K
ULTA icon
27
Ulta Beauty
ULTA
$22B
$6.34M 1.83%
16,450
-651
-4% -$259K
BAC icon
28
Bank of America
BAC
$431B
$6.26M 1.8%
201,081
-8,120
-4% -$292K
ACN icon
29
Accenture
ACN
$106B
$5.81M 1.67%
20,920
-2,219
-10% -$667K
WOOF icon
30
Petco
WOOF
$808M
$5.8M 1.67%
393,775
-19,270
-5% -$350K
MS icon
31
Morgan Stanley
MS
$323B
$5.53M 1.59%
72,727
-35,846
-33% -$2.94M
SBUX icon
32
Starbucks
SBUX
$119B
$4.25M 1.23%
55,682
-4,600
-8% -$353K
ROK icon
33
Rockwell Automation
ROK
$51.4B
$3.69M 1.07%
18,533
-1,676
-8% -$378K
XOM icon
34
ExxonMobil
XOM
$646B
$3.53M 1.02%
41,260
+36,593
+784% +$3.3M
F icon
35
Ford
F
$62B
$3.42M 0.99%
307,545
-19,715
-6% -$270K
BX icon
36
Blackstone
BX
$104B
$3.36M 0.97%
36,878
-25
-0.1% -$2.7K
DE icon
37
Deere & Co
DE
$166B
$3M 0.87%
10,022
+8,720
+670% +$3.21M
ASML icon
38
ASML
ASML
$611B
$2.83M 0.82%
5,947
-391
-6% -$218K
MRK icon
39
Merck
MRK
$322B
$2.65M 0.77%
29,112
NVDA icon
40
NVIDIA
NVDA
$4.7T
$1.83M 0.53%
121,050
-2,670
-2% -$50.4K
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.14T
$1.7M 0.49%
15,540
-100
-0.6% -$11.8K
REGN icon
42
Regeneron Pharmaceuticals
REGN
$73.1B
$1.36M 0.39%
2,308
+3
+0.1% +$1.95K
CCI icon
43
Crown Castle
CCI
$34.3B
$1.25M 0.36%
7,408
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.05M 0.3%
3,864
-30
-0.8% -$9.41K
SCHW.PRD
45
Charles Schwab 5.95% Series D Preferred Stock
SCHW.PRD
$719M
$877K 0.25%
35,160
-8,738
-20% -$219K
ZBRA icon
46
Zebra Technologies
ZBRA
$13.6B
$830K 0.24%
2,825
-25
-0.9% -$8.71K
SSNC icon
47
SS&C Technologies
SSNC
$19B
$826K 0.24%
14,232
-16
-0.1% -$1.03K
MCD icon
48
McDonald's
MCD
$193B
$810K 0.23%
3,280
WMT icon
49
Walmart Inc
WMT
$911B
$702K 0.2%
17,325
MDT icon
50
Medtronic
MDT
$112B
$672K 0.19%
7,487
-10
-0.1% -$1.01K

Similar funds

Cyrus J. Lawrence's Q2 2022 Portfolio in Review

As of Q2 2022, Cyrus J. Lawrence held 282 positions worth $347M, down 21% from $437M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Cyrus J. Lawrence withdrew a net $21.1M in Q2 2022, closing 24 positions and reducing 67 holdings. Its most notable exit was Generac Holdings, an estimated $4.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Cyrus J. Lawrence opened a new position in Vanguard Dividend Appreciation ETF worth $557K.

  • Cyrus J. Lawrence's largest Q2 2022 buy was Vanguard Dividend Appreciation ETF: 3,880 shares worth $557K.
  • Cyrus J. Lawrence added most to UnitedHealth in Q2 2022, an estimated $7.3M increase.
  • Cyrus J. Lawrence's biggest Q2 2022 reduction was Abbott, cutting an estimated $8.29M.
  • Cyrus J. Lawrence fully exited Generac Holdings in Q2 2022, selling an estimated $4.26M.
  • Cyrus J. Lawrence's ten largest holdings make up 38% of its $347M portfolio in Q2 2022.
  • Cyrus J. Lawrence opened 14 new positions and closed 24 in Q2 2022.
  • Cyrus J. Lawrence's portfolio value fell 21% quarter-over-quarter to $347M.

Based on Cyrus J. Lawrence's 13F filing for Q2 2022, filed 5 Aug 2022.